Li Hui Chang

Director of Finance/CFO at FORMOSA OPTICAL TECHNOLOGY CO.,LTD.

Health Technology

Process Industries

Consumer Services

Profile

Li Hui Chang is currently working as a Director at Polylite Taiwan Co. Ltd., a Director at Essilor Amera Pte Ltd., and as the Vice President-Finance & Accounting Office at Formosa Optical Technology Co., Ltd.
Mr. Chang completed their undergraduate degree at Fu Jen Catholic University.

Li Hui Chang active positions

Companies	Position	Start
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Director of Finance/CFO	1995-11-05
POLYLITE TAIWAN CO., LTD.	Director/Board Member	2006-05-31
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Director/Board Member	-

All active positions of Li Hui Chang

Training of Li Hui Chang

Fu Jen Catholic University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Li Hui Chang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Health Technology
POLYLITE TAIWAN CO., LTD.	Process Industries

Private companies	1
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Health Technology